B
Bradley D. Charette
Researcher at Scripps Research Institute
Publications - 5
Citations - 539
Bradley D. Charette is an academic researcher from Scripps Research Institute. The author has contributed to research in topics: Reprogramming & Induced pluripotent stem cell. The author has an hindex of 3, co-authored 5 publications receiving 521 citations.
Papers
More filters
Journal ArticleDOI
Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4
Costas A. Lyssiotis,Ruth K. Foreman,Judith Staerk,Michael Garcia,Divya Mathur,Styliani Markoulaki,Jacob H. Hanna,Luke L. Lairson,Bradley D. Charette,Laure C. Bouchez,Michael J. Bollong,Conrad Kunick,Achim Brinker,Charles Y. Cho,Peter G. Schultz,Rudolf Jaenisch +15 more
TL;DR: A small-molecule screening platform applied to identify compounds that functionally replace the reprogramming factor Klf4 gave rise to iPS cells that are indistinguishable from murine embryonic stem cells, and can be used to screen large chemical libraries in search of novel compounds to replace theReprogramming factors that induce pluripotency.
Journal ArticleDOI
A small molecule accelerates neuronal differentiation in the adult rat
Heiko Wurdak,Shoutian Zhu,Kyung-Hoon Min,Lindsey Aimone,Luke L. Lairson,James E. M. Watson,Chopiuk Greg,James A. Demas,Bradley D. Charette,Rajkumar Halder,Eranthie Weerapana,Benjamin F. Cravatt,Hollis T. Cline,Eric C. Peters,Jay Zhang,John R. Walker,Chunlei Wu,Jonathan Chang,Tove Tuntland,Charles Y. Cho,Peter G. Schultz +20 more
TL;DR: The characterization of a small molecule (KHS101) that selectively induces a neuronal differentiation phenotype that accelerates neuronal differentiation by interaction with TACC3 and may provide a basis for pharmacological intervention directed at endogenous NPCs.
Journal ArticleDOI
Pan-Src family kinase inhibitors replace Sox2 during the direct reprogramming of somatic cells.
Judith Staerk,Costas A. Lyssiotis,Lea A. Medeiro,Michael J. Bollong,Ruth K. Foreman,Shoutian Zhu,Michael Garcia,Qing Gao,Laure C. Bouchez,Luke L. Lairson,Bradley D. Charette,Lubica Supekova,Jeffrey Janes,Achim Brinker,Charles Y. Cho,Rudolf Jaenisch,Peter G. Schultz +16 more
TL;DR: In this paper, a small molecule replacement of the Src family of kinases was found to promote the formation of neomycin-resistant iPS cells in the absence of Dox.
Pan-Src Family Kinase Inhibitors Replace Sox2 during the Direct Reprogramming of Somatic Cells
Judith Staerk,Costas A. Lyssiotis,Lea A. Medeiro,Michael J. Bollong,Ruth K. Foreman,Shoutian Zhu,Michael Garcia,Qing Gao,Laure C. Bouchez,Luke L. Lairson,Bradley D. Charette,Lubica Supekova,Jeffrey Janes,Achim Brinker,Charles Y. Cho,Rudolf Jaenisch,Peter G. Schultz +16 more
TL;DR: A reporter based screen was exploited to identify a new class of compounds that functionally replace Sox2: inhibitors of the Src family of kinases, which provide novel tools to study the molecular mechanism of Sox2 in reprogramming.